PEPTID-NUKLEINSÄURE-KONJUGATE

European patent · EP3554556 · In force

Register entry

Publication number
EP3554556
Application number
EP17835751
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 18, 2017
Published
Oct 23, 2019
Granted
Mar 9, 2022
Protection ends at the latest
Dec 17, 2037
Next annual fee due
Dec 31, 2026
IPC classes
A61K 47/68 (2017.01)
A61K 49/00 (2006.01)
G01N 33/58 (2006.01)
C12Q 1/6823 (2018.01)
C12Q 1/6816 (2018.01)
G01N 33/532 (2006.01)
Priority
US 201662436189 P 19.12.2016
PCT application
PCT/US2017/066976 18.12.2017
PCT publication
WO2018/118759 28.06.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 18, 2023

    Change

    Published in Swissreg on 18.01.2023

  5. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  6. Mar 9, 2022

    Granted

    Published in Swissreg on 09.03.2022

Parties

Holder

Ventana Medical Systems, Inc.

1910 E. Innovation Park Drive, Tucson, Arizona 85755, US

Inventor

HONG, Rui

Oro Valley AZ 85737, US

BARHOUMI, Aoune

Oro Valley AZ 85737, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.